The University of Chicago Header Logo

Connection

Russell Z. Szmulewitz to Carcinoma, Neuroendocrine

Back to Details
This is a "connection" page, showing publications Russell Z. Szmulewitz has written about Carcinoma, Neuroendocrine.
Russell Z. Szmulewitz
Connection Strength
0.158
Carcinoma, Neuroendocrine
  1. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers. Clin Cancer Res. 2019 01 01; 25(1):43-51.
    View in: PubMed
    Score: 0.158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.